Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement
This study is investigating how smart, connected insulin pens and continuous glucose monitors (CGM) can improve diabetes management for adults who rely on caregivers. Often, when people with diabetes are older or need help with their care, their blood sugar levels can be poorly controlled, and important tools like CGM aren't used enough. This research aims to understand if providing caregivers with advice on how to use these modern devices can lead to better insulin control. The hope is to prevent problems like very low blood sugar and reduce the need for hospital visits. Participants will already be using these devices, and the study will observe how giving guidance to their carers affects their diabetes care over time.
At a glance
What is this study about?
This study is about making diabetes care better for adults who need support to manage their condition. This might include people who live in care homes or those who have caregivers at home. Sometimes, for these individuals, keeping blood sugar levels stable can be tricky, and important technology like continuous glucose monitors (CGMs) isn't used as much as it could be. CGM devices measure blood sugar levels consistently throughout the day and night.
Researchers have noticed that caregivers, whether at home or in institutions, might not always use insulin therapy in the most effective way. There's also evidence from other studies that older people with diabetes often experience very low blood sugar levels during the night. These emergencies, which sometimes lead to hospital stays, can happen because of mistakes in insulin doses or unclear instructions. Smart insulin pens, which link to apps and can track insulin doses, have already shown promise in helping people with Type 1 diabetes manage their condition better.
The main goal of this study is to find out if providing advice and support to caregivers on how to use smart insulin pens and continuous glucose monitors can improve daily insulin management. The researchers will be studying the day-to-day use of these devices in participants who are already using them. They hope to see fewer problems with blood sugar control and a smoother experience with diabetes care once caregivers receive guidance.
Key takeaways
- This study aims to make diabetes care better for adults who need help with their insulin.
- It focuses on how smart insulin pens and continuous glucose monitors can be used more effectively.
- Caregivers will receive advice to help improve their patient's diabetes management.
- The goal is to prevent blood sugar problems and reduce hospital visits.
- Participants must already be using specific diabetes devices.
Who may be eligible?
To join this study, you need to be an adult (18 years or older) with either Type 1 or Type 2 diabetes. You must be using multiple insulin injections each day to manage your diabetes.
An important part of this study is that you should already be using a continuous glucose monitoring (CGM) system and smart, connected insulin pens for at least one month before the study starts. You also need to rely on a healthcare professional or caregiver to help you manage your diabetes treatment.
Finally, you need to be aware of the study and agree to your health information being collected for research purposes. If you don't want to be in the study, that's perfectly fine, and you wouldn't be included.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have Type 1 or Type 2 diabetes and use multiple insulin injections?
- Have you been using a continuous glucose monitor (CGM) and smart insulin pens for at least a month?
- Do you rely on a caregiver or healthcare worker to help manage your insulin treatment?
What does participation involve?
If you join this study, you will continue your existing diabetes care as usual, which includes using your continuous glucose monitor and smart insulin pens. The study observes how providing advice to your caregivers impacts your diabetes management. There are no extra hospital visits or new medications involved for you. The main focus is on the support and guidance given to the person who helps you with your insulin. The total duration of your participation isn't specified, but it involves observing your existing routine.
Potential risks and benefits
Locations (1)
- Centre Hospitalier Sud FrancilienVerified postcodeCorbeil-Essonnes, France· Recruiting
Common questions
What kind of diabetes do I need to have to join?
You can have either Type 1 or Type 2 diabetes to be considered for this study, as long as you use insulin.
Do I need to buy a smart insulin pen or CGM for this study?
No, you must already be using a continuous glucose monitor (CGM) and smart insulin pens at least a month before joining.
What does 'dependent' patient mean in this study?
It means you rely on a helper (a healthcare professional or caregiver) to manage your insulin treatment.
Will I have to take any new medicines?
No, this study only looks at how existing treatments are managed with current devices; no new medicines are given.
How long will I be part of the study?
The study description doesn't give a specific timeframe, but it involves observing your ongoing diabetes care.
How to find out more
Marie BOULY, APN
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.